Delivery Order SPE2DB20D9157-SPE2DB23FG62B
Award Date 5/26/23
Potential Completion Date 5/30/23
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $8,643.02. The place of performance is Park Ridge, Illinois and all items are to be delivered by November 10, 2022. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and supply chain management for the...
- This delivery order, awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $4,311.35. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 6, 2023. No set-aside designation was used for this award placed under an unidentified medical supply vehicle. The Defense Logistics Agency Troop Support Medical...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,964.50. The place of performance is Park Ridge, Illinois and all items are to be delivered by December 12, 2022. No set-aside designation was used for this order placed under an existing DLA pharmaceutical supply contract vehicle. As the Defense Logistics Agency's primary role includes procuring, managing and...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $8,622.70. The place of performance is Park Ridge, Illinois and all items are to be delivered by June 7, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement, distribution and supply chain management for the United...
- The Defense Logistics Agency (DOD) awarded a $8,622.70 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. The delivery order was issued under an unspecified government-wide acquisition contract vehicle and has a period of performance from August 11-14, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing medical supplies to...
- The Defense Logistics Agency (DOD) awarded a delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. as the prime contractor. The firm fixed price order is for the delivery of 120 capsules of XTANDI 40 MG to a facility located in Park Ridge, Illinois. The period of performance is limited to a single day, running from August 14, 2023 to August 15, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-four thousand four hundred ninety dollars and eighty cents ($34,490.80) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois, and the period of performance is one day from June 29, 2023 to June 30, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $34,490.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of 120 capsules of XTANDI 40 MG CAPSULE. The place of performance will be Park Ridge, Illinois and the period of performance is from August 11, 2023 through August 14, 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. valued at approximately seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois and is required to be completed by May 2, 2023. The order was awarded on May 1, 2023 under an existing contract vehicle and no set-aside designation was applied. XTANDI...
- This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the provision of 120 capsules of XTANDI 40 MG CAPSULE. The order has a potential value of $77,604.30 under a firm fixed price arrangement. Performance will occur in Park Ridge, Illinois with an anticipated completion date of October 16, 2023. No set-aside designation was applied to this award made in support of the Defense Logistics Agency's pharmaceutical procurement and distribution programs.
- SPE2DB20D9157Indefinite Delivery Contract
- SPE2DB20D9157-SPE2DB23FG62BDelivery Order
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $12,934.05. Performance will occur in Park Ridge, Illinois, with delivery required by May 30, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support for the U.S. military, this order is likely intended to supply prostate cancer medication to military treatment facilities.
Generated 1/3/24, 2:39 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 5/26/23 |